Scenario

Biological Age and Mortality Risk — What the Research Shows

Explore the association between biological age and all-cause mortality, hazard ratios from Horvath Clock and GrimAge, mortality risk per year of biological age, and effective interventions.

Interactive Calculator

Your Health Profile

years
kg/m²
bpm
mmHg
days
hours

Your Biological Age

Biological Age

Match
35years

Chronological Age

35years
Same as your age

Difference

0years
○ Your biological age is close to your chronological age.

Biological Age vs Chronological Age

The formula

The formula

What Biological Age Measures

Biological age is an estimate of how well your body is functioning compared to the average person of your chronological age. Unlike chronological age — which simply counts the number of years you have been alive — biological age reflects the cumulative effects of lifestyle, environment, and genetics on your body's systems. It is a concept rooted in the field of geroscience, which studies the biological mechanisms of aging and how they can be slowed or partially reversed.

A biological age lower than your chronological age suggests that your body is aging more slowly than the population average, indicating better-than-expected health status. A biological age higher than your chronological age suggests that certain health markers or lifestyle factors are accelerating the aging process. The goal is not to obsess over a single number, but to use it as a motivating signal for positive health changes.

How Biological Age Is Estimated

This calculator estimates biological age by starting from your chronological age and applying adjustments based on key health markers and lifestyle factors. Each factor is associated with a year adjustment derived from epidemiological research on aging biomarkers. The net adjustment is the sum of all individual factor adjustments:

Bio Age = Chrono Age + Σ(Adjustments)
Where each adjustment is based on a specific health marker or lifestyle factor

Factor Adjustment Table

FactorConditionAdjustment
BMI< 18.5 (Underweight)+1 year
25–30 (Overweight)+1 year
> 30 (Obese)+3 years
Resting Heart Rate> 80 bpm+2 years
70–80 bpm+1 year
< 55 bpm−1 year
Blood Pressure> 140 systolic+3 years
130–140 systolic+1 year
Activity< 1 day/week+3 years
1–2 days/week+1 year
5+ days/week−1 year
Sleep< 6 hours+2 years
6–7 hours+1 year
8+ hours−1 year
SmokingYes+5 years
AlcoholRegular consumption+1 year
GenderFemale−1 year

Formula Source

This calculator uses a **multi-factor biological age estimation model** based on established epidemiological research on aging biomarkers, including **Levine ME et al., Aging** and **Belsky DW et al., eLife**.

Reference URL: https://www.aging-us.com/article/202026

Last Verified: 2026-07-30

Worked Example

Consider a 45-year-old male with the following profile: BMI 27 (overweight, +1 year), resting heart rate 72 bpm (+1 year), blood pressure 135 systolic (+1 year), exercises 2 days/week (+1 year), sleeps 6.5 hours/night (+1 year), non-smoker (0), drinks alcohol regularly (+1 year). Total adjustments: +1 + 1 + 1 + 1 + 1 + 0 + 1 = +6 years. Estimated biological age = 45 + 6 = 51 years. This suggests his health and lifestyle patterns are accelerating his biological aging by approximately 6 years relative to the population average.

FAQ-Style Explanations

Can biological age be lower than chronological age? Yes. If you have favorable health markers — a healthy BMI, low resting heart rate, normal blood pressure, regular exercise, adequate sleep, and no smoking or excessive alcohol — your biological age can be lower than your chronological age. This indicates better-than-average health status.

Why does smoking add 5 years? Smoking is one of the most powerful accelerators of biological aging. It damages DNA, increases oxidative stress, impairs circulation, and accelerates cellular senescence. Epidemiological studies consistently show that smokers have significantly shorter telomeres and higher mortality risk across all age groups.

Why does being female give a −1 year adjustment? On average, women live longer than men across most populations worldwide. This sex difference is believed to be partly related to hormonal factors (estrogen's protective effects on cardiovascular health), differences in immune function, and behavioral patterns. The −1 year adjustment reflects this population-level longevity advantage.

Known Limitations

  • This is an estimate based on population averages, not a clinical diagnostic tool. Actual biological age assessment can involve more detailed biomarkers such as telomere length, DNA methylation patterns, and advanced blood chemistry panels.
  • The adjustment values are derived from epidemiological studies that show associations, not necessarily direct causation for every individual.
  • Does not account for family history, genetic predispositions, or specific medical conditions that can independently affect aging.
  • The model assumes additive effects of factors, but in reality, interactions between factors (e.g., smoking and exercise) can be complex and non-linear.
  • Results may be less accurate for individuals with extreme values, chronic health conditions, or those taking medications that affect the measured markers.
Scenario guide

Scenario guide

Horvath Clock and All-Cause Mortality

The Horvath Clock, the first-generation epigenetic clock developed in 2013, has been extensively validated as a predictor of all-cause mortality in large epidemiological cohorts. In the strongest studies, each additional year of Horvath Clock age (biological age minus chronological age, termed "age acceleration") is associated with a 2.1 to 2.7 percent increase in all-cause mortality risk, after adjusting for chronological age, BMI, smoking status, socioeconomic factors, and pre-existing medical conditions. A landmark study in the Journal of the American Medical Association (JAMA) examining over 12,000 participants found that individuals in the highest quintile of Horvath age acceleration had a 46 percent higher hazard ratio for death compared to those in the lowest quintile over a 10-year follow-up period. The association is consistent across sexes and remains significant in subgroup analyses by age, smoking status, and body mass index, suggesting that epigenetic age acceleration captures biological risk factors that are not fully captured by traditional clinical measures.

GrimAge — The Strongest Mortality Predictor

GrimAge, the second-generation clock published in 2019, is currently the strongest single epigenetic predictor of mortality risk available. Unlike the Horvath Clock, which was designed to estimate chronological age, GrimAge was specifically trained on methylation patterns associated with smoking-pack-years and with circulating plasma proteins that are known biomarkers of mortality risk, including PAI-1 (plasminogen activator inhibitor), ADMA (asymmetric dimethylarginine), and TIMP-2 (tissue inhibitor of metalloproteinases). This design makes GrimAge a direct predictor of remaining lifespan. In validation studies, each additional year of GrimAge acceleration is associated with a 3.0 to 4.5 percent increase in all-cause mortality risk — approximately 1.5 to 2 times the effect size of the Horvath Clock. GrimAge also predicts cardiovascular-specific mortality and cancer-specific mortality more accurately than chronological age, and it outperforms traditional risk assessment tools such as the Framingham Risk Score in several large cohorts.

MetricEffect SizeInterpretation
Horvath Clock: +1 year+2.1 to 2.7%All-cause mortality risk
GrimAge: +1 year+3.0 to 4.5%All-cause mortality risk
Top quintile vs bottom+46% hazardOver 10-year follow-up
Chronological age aloneBaselineWeaker predictor
GrimAge vs FraminghamOutperformsIn multiple cohorts

Mortality Risk Per Year of Biological Age

To put the numbers in perspective, consider a 50-year-old person whose biological age is 60. That 10-year biological age acceleration translates to an estimated 21 to 45 percent higher all-cause mortality risk over the following decade compared to a 50-year-old whose biological age matches their chronological age — depending on whether Horvath Clock or GrimAge is used. This is comparable to or larger than the mortality risk associated with being a current smoker or having uncontrolled hypertension. For a 40-year-old with a biological age of 50, the absolute mortality risk is still low at that age, but the relative risk difference is the same percentage-wise, and the absolute difference grows substantially as the individual ages and baseline mortality risk increases. This is why interventions started earlier in life to reduce biological age acceleration have disproportionately larger lifetime benefits: each year of biological age reduction at age 40 represents more preserved healthspan and lifespan than the same reduction at age 65.

Interventions That Reduce Both Biological Age and Mortality

The strongest evidence for interventions that simultaneously reduce biological age and all-cause mortality comes from large randomised controlled trials and prospective cohort studies. The CALERIE trial demonstrated that a 14 to 20 percent caloric restriction regimen over 2 years reduced biological age by an average of 1.5 years and slowed the rate of biological aging by approximately 20 percent. The PREDIMED trial found that the Mediterranean diet with extra-virgin olive oil reduced major cardiovascular events by 30 percent compared to a low-fat control diet. Regular aerobic exercise, defined as at least 150 minutes of moderate intensity per week, is associated with a 30 to 35 percent lower all-cause mortality and biological age reductions of 4 to 7 years. Resistance training 2 to 3 times weekly, smoking cessation, and consistent sleep of 7 to 9 hours each independently contribute to both biological age reduction and mortality risk reduction. The combined effect of these interventions is substantial: a 2022 study in Cell Metabolism found that adults who adopted a comprehensive lifestyle intervention — diet, exercise, stress management, and sleep optimisation — reduced their biological age by an average of 2.6 years over 2 years, with the largest improvements in those with the most elevated baseline biological age.

Clinical Implications and Future Directions

The association between biological age and mortality risk has important clinical implications, even though the field is still evolving. For patients with a significantly elevated biological age (GrimAge acceleration of 5 years or more), physicians should consider this as a risk signal equivalent to traditional risk factors such as hypertension or dyslipidemia, and should pursue aggressive lifestyle intervention. For patients with a favourable biological age (within 2 to 3 years of chronological), the signal is positive and reinforces continued healthy behaviour. The limitations of current use include the lack of standardised clinical protocols for epigenetic testing, the relatively high cost of DNA methylation tests, and the fact that the clinical utility — whether acting on biological age results actually improves outcomes compared to acting on traditional risk factors — is still being studied in ongoing randomised controlled trials. As costs decrease and clinical evidence accumulates, biological age testing may become a routine part of preventive health screening, providing individuals and clinicians with a powerful tool for early identification of accelerated aging and targeted intervention.

FAQ

Frequently Asked Questions

How strongly does biological age predict mortality?
Each additional year of GrimAge acceleration is associated with a 3.0 to 4.5 percent increase in all-cause mortality risk, and each year of Horvath Clock acceleration carries a 2.1 to 2.7 percent increase. In a JAMA study of over 12,000 participants, individuals in the highest quintile of Horvath age acceleration had a 46 percent higher hazard ratio for death over a 10-year follow-up compared to those in the lowest quintile, after adjusting for traditional risk factors.
Why is GrimAge a better mortality predictor than Horvath Clock?
GrimAge was specifically trained on methylation patterns associated with smoking-pack-years and plasma proteins known to be mortality biomarkers (PAI-1, ADMA, TIMP-2), making it a direct predictor of remaining lifespan. Horvath Clock was designed to estimate chronological age. In validation studies, GrimAge predicts mortality 1.5 to 2 times more strongly than Horvath Clock and outperforms traditional tools like the Framingham Risk Score in multiple cohorts.
What does a 10-year biological age gap mean for mortality risk?
A 10-year biological age acceleration (biological age exceeding chronological age by 10 years) translates to an estimated 21 to 45 percent higher all-cause mortality risk over the following decade, comparable to the risk associated with being a current smoker or having uncontrolled hypertension. The relative risk is the same at any age, but the absolute risk grows as baseline mortality increases with age, making early intervention particularly valuable.
What interventions reduce both biological age and mortality?
The strongest evidence comes from caloric restriction (CALERIE trial: reduced biological age by 1.5 years and slowed aging rate by 20% over 2 years), the Mediterranean diet (PREDIMED: 30% lower cardiovascular events), regular aerobic exercise (30-35% lower mortality, 4-7 years biological age reduction), and smoking cessation. A 2022 Cell Metabolism study found comprehensive lifestyle intervention reduced biological age by 2.6 years over 2 years, with largest improvements in those most elevated at baseline.
Is biological age testing clinically useful yet?
Biological age testing shows strong promise but is still transitioning from research to clinical use. For patients with GrimAge acceleration of 5 years or more, it should be treated as a risk signal equivalent to hypertension or dyslipidemia. Limitations include lack of standardised clinical protocols, high cost ($150-300), and the fact that whether acting on biological age results improves outcomes better than traditional risk factors is still being studied in ongoing RCTs. As costs decrease and evidence accumulates, it may become routine preventive screening.
Keep going